The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 21, Issue 7, 2013, Pages 685-695

  Rosenberg, Paul B ^a   Mielke, Michelle M ^a   Appleby, Brian S ^a   Oh, Esther S ^a   Geda, Yonas E ^b   Lyketsos, Constantine G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer disease; Dementia; Depression; Longitudinal study; Mild cognitive impairment; Neuropsychiatric symptoms

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING GLOBAL SCORE AND SUM OF BOXES; DEMENTIA; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; INCIDENT DEMENTIA; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; PSYCHOLOGIC TEST; RISK ASSESSMENT; SYMPTOM;

EID: 85027941701     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.01.006     Document Type: Article

References (47)

1. Alzheimer's Association: 2009 Alzheimer's disease facts and figures. Alzheimers Dement 2009; 5:234-270
2. Riley KP, Snowdon DA, Desrosiers MF, et al: Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging 2005; 26:341-347 (Pubitemid 40082717)
3. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256:183-194 (Pubitemid 39222988)
4. Dickerson BC, Sperling RA, Hyman BT, et al: Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007; 64: 1443-1450 (Pubitemid 350223563)
5. Okello A, Koivunen J, Edison P, et al: Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 2009; 73:754-760
6. Mattsson N, Zetterberg H, Hansson O, et al: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009; 302:385-393
7. Leung KK, Barnes J, Ridgway GR, et al: Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 2010; 51(4):1345-1359
8. Steinberg M, Shao H, Zandi P, et al: Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 2008; 23:170-177 (Pubitemid 351308497)
9. Geda YE, Roberts RO, Knopman DS, et al: Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 2008; 65:1193-1198
10. Rosenberg PB, Mielke MM, Appleby B, et al: Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry 2011; 26(4):364-372
11. Teng E, Lu PH, Cummings JL: Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24: 253-259 (Pubitemid 47482071)
12. Robert PH, Berr C, Volteau M, et al: Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry 2008; 16:770-776
13. Palmer K, Di Iulio F, Varsi AE, et al: Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J Alzheimers Dis 2010; 20(1):175-183
14. Palmer K, Berger AK, Monastero R, et al: Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68:1596-1602 (Pubitemid 46717984)
15. Ramakers IH, Visser PJ, Aalten P, et al: Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study. Psychol Med 2010; 40: 1193-1201
16. Beekly DL, Ramos EM, Lee WW, et al: The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord 2007; 21:249-258 (Pubitemid 47367978)
17. Morris JC, Weintraub S, Chui HC, et al: The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006; 20: 210-216 (Pubitemid 44900933)
18. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414 (Pubitemid 23346995)
19. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
20. Wechsler D, Stone CP: Manual: Wechsler Memory Scale. New York, NY, Psychologic Corporation, 1973
21. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165 (Pubitemid 19239715)
22. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, PA, Lea and Febiger, 1983
23. Wechsler D: Manual: Wechsler Adult Intelligence Scale. New York, NY, Psychologic Corporation, 1955
24. Armitage SG: An analysis of certain psychological tests used in the evaluation of brain injury. Psych Mono 1946; 60:1-48
25. Morris JC, Ernesto C, Schafer K, et al: Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology 1997; 48: 1508-1510
26. Rockwood K, Strang D, MacKnight C, et al: Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc 2000; 48:558-559 (Pubitemid 30263110)
27. Fillenbaum GG, Peterson B, Morris JC: Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease. Aging (Milano) 1996; 8:379-385
28. Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9(suppl 1):173-176; discussion 177-178 (Pubitemid 28045357)
29. Pavlik VN, Doody RS, Massman PJ, et al: Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 22:367-377 (Pubitemid 44651453)
30. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314 (Pubitemid 24382728)
31. Kaufer DI, Cummings JL, Ketchel P, et al: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12:233-239 (Pubitemid 30303778)
32. Burke WJ, Roccaforte WH, Wengel SP: The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4:173-178
33. Korner A, Lauritzen L, Abelskov K, et al: The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A validity study. Nord J Psychiatry 2006; 60:360-364 (Pubitemid 44575513)
34. Debruyne H, Van Buggenhout M, Le Bastard N, et al: Is the Geriatric Depression Scale: a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment? Int J Geriatr Psychiatry 2009; 24:556-562
35. Hachinski VC, Iliff LD, Zilhka E, et al: Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637
36. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65-70
37. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526
38. Landau SM, Harvey D, Madison CM, et al: Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010; 75:230-238
39. Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, et al: Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology 2006; 67:229-234 (Pubitemid 44305404)
40. Taragano FE, Allegri RF, Krupitzki H, et al: Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry 2009; 70:584-592
41. Lyness SA, Zarow C, Chui HC: Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 2003; 24:1-23 (Pubitemid 35454140)
42. Capuron L, Miller AH: Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56:819-824
43. Heneka MT, O'Banion MK, Terwel D, et al: Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 2010; 117:919-947
44. Heneka MT, Nadrigny F, Regen T, et al: Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A 2010; 107: 6058-6063
45. Liu Y, Yoo MJ, Savonenko A, et al: Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 2008; 28:13805-13814
46. Grudzien A, Shaw P, Weintraub S, et al: Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2007; 28:327-335 (Pubitemid 46178530)
47. Farias ST, Mungas D, Reed BR, et al: Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009; 66:1151-1157